Martin Schmieg

Martin Schmieg

Directeur/Membre du Conseil chez BRIACELL THERAPEUTICS CORP.

Fortune : 17 $ au 31/03/2026

63 ans
Health Technology
Commercial Services
Finance

Profil

Martin E.
Schmieg
is the founder of Soar Ventures, founded in 2013, serving as General Manager since its founding.
Mr. Schmieg was the founder of ClearIt LLC, founded in 2013, and served as President, Chief Executive Officer & Director from 2013 to 2021.
Mr. Schmieg was the founder of Clear Intradermal Technologies, Inc., founded in 2003, and served as Chief Financial & Technology Officer from 2003 to 2021.
Current jobs include Chief Executive Officer at TrueBinding, Inc., Independent Director at BriaCell Therapeutics Corp.
since 2020, Chief Financial Officer & Director at Sapientia Pharmaceuticals, Inc., Managing Director at DIgSILENT Holding GmbH, Independent Director at BriaPro Therapeutics Corp., and Investment Advisor at Boutique Venture Partners LLC.
Former jobs include President & Chief Executive Officer at Freedom2, Inc. from 2006 to 2009; Chairman, President & Chief Executive Officer at PharmaCyte Biotech, Inc. from 2009 to 2010; Chief Financial Officer & Director at Rokk3r, Inc. in 2017; Independent Director at BriaCell Therapeutics Corp.
from 2016 to 2019; Chief Financial Officer at Sirna Therapeutics, Inc. from 2004 to 2005; Chief Financial Officer at Fibrocell Science, Inc. from 2005 to 2006; Chief Financial Officer at Advanced Bionics Corp.
from 2003 to 2004; Chief Financial Officer at Isolagen Technologies, Inc. from 2005 to 2006; Vice President at NeoStem, Inc. from 2012 to 2013; Vice President-Corporate Development at Caladrius Biosciences, Inc.; Chief Financial Officer at Cytometrics, Inc. from 1992 to 2000; and Chief Financial Officer at Rokk3r Labs LLC.
Education includes undergraduate studies at LaSalle University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
07/07/2026 4 ( 0 % ) 14 $ 31/07/2026
0,5 %
01/04/2026 359 575 ( 0,5 % ) 4 $ 31/03/2026

Postes actifs de Martin Schmieg

SociétésPosteDébut
BRIACELL THERAPEUTICS CORP. Directeur/Membre du Conseil 24/11/2020
Directeur/Membre du Conseil -
Consultant / Advisor -
Directeur Général -
Directeur Financier/CFO -
Directeur Général 01/01/2013
Directeur Général -

Anciens postes connus de Martin Schmieg

SociétésPosteFin
Fondateur 01/11/2021
Fondateur 01/11/2021
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Martin Schmieg

Formation de Martin Schmieg

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

57

Relations au 1er degré

21

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées21

Commercial Services

Commercial Services

Miscellaneous

Health Technology

Consumer Non-Durables

Commercial Services

Consumer Services

Transportation

Health Technology

Health Services

Health Technology

Finance

Health Technology

Distribution Services

Finance

Producer Manufacturing

Commercial Services

Health Technology

Finance

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Martin Schmieg
🔇